Corridor Pharmaceuticals Report issue

For profit Phase 2
Founded: Towson MD United States (2007)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

Key: Corridor Pharmaceuticals (0) Acquired (1)

fluphenazine (permitil) (4 trials)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 4
  • # of Trial APIs: 1